Literature DB >> 29158429

B Cell Presentation of Chlamydia Antigen Selects Out Protective CD4γ13 T Cells: Implications for Genital Tract Tissue-Resident Memory Lymphocyte Clusters.

Raymond M Johnson1, Hong Yu2, Norma Olivares Strank3, Karuna Karunakaran2, Ying Zhu4, Robert C Brunham2.   

Abstract

Surveillance and defense of the enormous mucosal interface with the nonsterile world are critical to protecting the host from a wide range of pathogens. Chlamydia trachomatis is an intracellular bacterial pathogen that replicates almost exclusively in the epithelium of the reproductive tract. The fallopian tubes and vagina are poorly suited to surveillance and defense, with limited immune infrastructure positioned near the epithelium. However, a dynamic process during clearing primary infections leaves behind new lymphoid clusters immediately beneath the epithelium. These memory lymphocyte clusters (MLCs) harboring tissue-resident memory (Trm) T cells are presumed to play an important role in protection from subsequent infections. Histologically, human Chlamydia MLCs have prominent B cell populations. We investigated the status of genital tract B cells during C. muridarum infections and the nature of T cells recovered from immune mice using immune B cells as antigen-presenting cells (APCs). These studies revealed a genital tract plasma B cell population and a novel genital tract CD4 T cell subset producing both gamma interferon (IFN-γ) and interleukin-13 (IL-13). A panel of CD4 T cell clones and microarray analysis showed that the molecular fingerprint of CD4γ13 T cells includes a Trm-like transcriptome. Adoptive transfer of a Chlamydia-specific CD4γ13 T cell clone completely prevented oviduct immunopathology without accelerating bacterial clearance. Existence of a CD4γ13 T cell subset provides a plausible explanation for the observation that human peripheral blood mononuclear cell (PBMC) Chlamydia-specific IFN-γ and IL-13 responses predict resistance to reinfection.
Copyright © 2018 American Society for Microbiology.

Entities:  

Keywords:  B cells; CD4; Chlamydia; IL-13; Trm

Mesh:

Year:  2018        PMID: 29158429      PMCID: PMC5778355          DOI: 10.1128/IAI.00614-17

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  58 in total

1.  Vaccination with the Chlamydia trachomatis major outer membrane protein can elicit an immune response as protective as that resulting from inoculation with live bacteria.

Authors:  Sukumar Pal; Ellena M Peterson; Luis M de la Maza
Journal:  Infect Immun       Date:  2005-12       Impact factor: 3.441

2.  Protection Against Chlamydia trachomatis Infection and Upper Genital Tract Pathological Changes by Vaccine-Promoted Neutralizing Antibodies Directed to the VD4 of the Major Outer Membrane Protein.

Authors:  Anja W Olsen; Frank Follmann; Karin Erneholm; Ida Rosenkrands; Peter Andersen
Journal:  J Infect Dis       Date:  2015-03-06       Impact factor: 5.226

3.  Immunoepidemiologic profile of Chlamydia trachomatis infection: importance of heat-shock protein 60 and interferon- gamma.

Authors:  Craig R Cohen; Kasra M Koochesfahani; Amalia S Meier; Caixia Shen; Karuna Karunakaran; Beartrice Ondondo; Teresa Kinyari; Nelly R Mugo; Rosemary Nguti; Robert C Brunham
Journal:  J Infect Dis       Date:  2005-07-07       Impact factor: 5.226

4.  In situ analysis of the evolution of the primary immune response in murine Chlamydia trachomatis genital tract infection.

Authors:  S G Morrison; R P Morrison
Journal:  Infect Immun       Date:  2000-05       Impact factor: 3.441

5.  The unexpected impact of a Chlamydia trachomatis infection control program on susceptibility to reinfection.

Authors:  Robert C Brunham; Babak Pourbohloul; Sunny Mak; Rick White; Michael L Rekart
Journal:  J Infect Dis       Date:  2005-10-10       Impact factor: 5.226

6.  An atypical CD8 T-cell response to Chlamydia muridarum genital tract infections includes T cells that produce interleukin-13.

Authors:  Raymond M Johnson; Micah S Kerr; James E Slaven
Journal:  Immunology       Date:  2014-06       Impact factor: 7.397

7.  Role of T lymphocytes in the pathogenesis of Chlamydia disease.

Authors:  Joseph U Igietseme; Qing He; Kahaliah Joseph; Francis O Eko; Deborah Lyn; Godwin Ananaba; Angela Campbell; Claudiu Bandea; Carolyn M Black
Journal:  J Infect Dis       Date:  2009-09-15       Impact factor: 5.226

8.  Age and clinical immunity to infections with Chlamydia trachomatis.

Authors:  J N Arno; B P Katz; R McBride; G A Carty; B E Batteiger; V A Caine; R B Jones
Journal:  Sex Transm Dis       Date:  1994 Jan-Feb       Impact factor: 2.830

9.  Critical role for interleukin-1beta (IL-1beta) during Chlamydia muridarum genital infection and bacterial replication-independent secretion of IL-1beta in mouse macrophages.

Authors:  Daniel Prantner; Toni Darville; James D Sikes; Charles W Andrews; Helmut Brade; Roger G Rank; Uma M Nagarajan
Journal:  Infect Immun       Date:  2009-10-05       Impact factor: 3.441

10.  Human female genital tract infection by the obligate intracellular bacterium Chlamydia trachomatis elicits robust Type 2 immunity.

Authors:  Rodolfo D Vicetti Miguel; Stephen A K Harvey; William A LaFramboise; Seth D Reighard; Dean B Matthews; Thomas L Cherpes
Journal:  PLoS One       Date:  2013-03-13       Impact factor: 3.240

View more
  14 in total

1.  Antibody, but not B-cell-dependent antigen presentation, plays an essential role in preventing Chlamydia systemic dissemination in mice.

Authors:  Priyangi A Malaviarachchi; Miguel A B Mercado; Stephen J McSorley; Lin-Xi Li
Journal:  Eur J Immunol       Date:  2020-03-12       Impact factor: 5.532

Review 2.  Diversity in the T cell response to Chlamydia-sum are better than one.

Authors:  Jasmine C Labuda; Stephen J McSorley
Journal:  Immunol Lett       Date:  2018-09-01       Impact factor: 3.685

3.  Chlamydia muridarum Induces Pathology in the Female Upper Genital Tract via Distinct Mechanisms.

Authors:  Heze Yu; Hui Lin; Lingxiang Xie; Lingli Tang; Jianlin Chen; Zhiguang Zhou; Jiangdong Ni; Guangming Zhong
Journal:  Infect Immun       Date:  2019-07-23       Impact factor: 3.441

4.  Innate IFN-γ Is Essential for Systemic Chlamydia muridarum Control in Mice, While CD4 T Cell-Dependent IFN-γ Production Is Highly Redundant in the Female Reproductive Tract.

Authors:  Miguel A B Mercado; Wuying Du; Priyangi A Malaviarachchi; Jessica I Gann; Lin-Xi Li
Journal:  Infect Immun       Date:  2021-02-16       Impact factor: 3.441

5.  Combining Cellular Immunology With RNAseq to Identify Novel Chlamydia T-Cell Subset Signatures.

Authors:  Raymond M Johnson; Hiromitsu Asashima; Subhasis Mohanty; Albert C Shaw
Journal:  J Infect Dis       Date:  2022-06-01       Impact factor: 7.759

6.  A Class II-Restricted CD8γ13 T-Cell Clone Protects During Chlamydia muridarum Genital Tract Infection.

Authors:  Raymond M Johnson; Norma Olivares-Strank; Gang Peng
Journal:  J Infect Dis       Date:  2020-05-11       Impact factor: 5.226

7.  Serum and Cervicovaginal Fluid Antibody Profiling in Herpes Simplex Virus-Seronegative Recipients of the HSV529 Vaccine.

Authors:  Kening Wang; Lesia Dropulic; Joel Bozekowski; Harlan L Pietz; Sinthujan Jegaskanda; Kennichi Dowdell; Joshua S Vogel; Doreen Garabedian; Makinna Oestreich; Hanh Nguyen; Mir A Ali; Keith Lumbard; Sally Hunsberger; Jack Reifert; Winston A Haynes; Jaymie R Sawyer; John C Shon; Patrick S Daugherty; Jeffrey I Cohen
Journal:  J Infect Dis       Date:  2021-11-16       Impact factor: 5.226

8.  Dual RNA-seq analysis of in vitro infection multiplicity and RNA depletion methods in Chlamydia-infected epithelial cells.

Authors:  Regan J Hayward; Michael S Humphrys; Wilhelmina M Huston; Garry S A Myers
Journal:  Sci Rep       Date:  2021-05-17       Impact factor: 4.379

Review 9.  Niches for the Long-Term Maintenance of Tissue-Resident Memory T Cells.

Authors:  Shiki Takamura
Journal:  Front Immunol       Date:  2018-05-31       Impact factor: 7.561

10.  Cellular Basis for the Enhanced Efficacy of the Fms-Like Tyrosine Kinase 3 Ligand (FL) Adjuvanted VCG-Based Chlamydia abortus Vaccine.

Authors:  Shakyra Richardson; Fnu Medhavi; Tayhlor Tanner; Stephanie Lundy; Yusuf Omosun; Joseph U Igietseme; Darin Carroll; Francis O Eko
Journal:  Front Immunol       Date:  2021-06-24       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.